Who Buys Clarithromycin from India — 811 Importers Behind a $98.4M Market
India's clarithromycin import market is served by 811 active buyers who collectively imported $98.4M across 3,576 shipments. BROWN AND BURK LIMITED (UNITED KINGDOM) leads with a 11.7% market share, followed by YUSEN LOGISTICS BENELUX BELGIUM and DYVENPRO DISTRIBUCION Y VENTA DE. The top 5 buyers together control 32.4% of total import value, reflecting a moderately competitive buyer landscape.
Top Clarithromycin Importers — Ranked by Import Value
BROWN AND BURK LIMITED (UNITED KINGDOM) is the leading clarithromycin importer from India, holding a 11.7% share of the $98.4M market across 3,576 shipments from 811 buyers. The top 5 buyers — BROWN AND BURK LIMITED (UNITED KINGDOM), YUSEN LOGISTICS BENELUX BELGIUM (BELGIUM), DYVENPRO DISTRIBUCION Y VENTA DE (ECUADOR), HEKO PHARMACY LTD (TANZANIA), CIPLA KENYA LTD C/O IMPERIAL MANAGE (KENYA) — collectively control 32.4% of total import value.
Top Clarithromycin Buyers & Importers
Ranked by import value · 811 active buyers · Indian Customs (DGFT) data
| # | Buyer & Formulations | Value | Suppliers | Share |
|---|---|---|---|---|
| 1 | BROWN AND BURK LIMITEDUNITED KINGDOM CLARITHROMYCIN FILM - COATED TABLETS 250CLARIWELL (CLARITHROMYCIN 250MG/5ML POWDCLARITHROMYCIN TABLETS 500 MG 2X7'S | $11.5M | 5 | 11.7% |
| 2 | YUSEN LOGISTICS BENELUX BELGIUMBELGIUM CLARITHROMYCIN BASICS TAB 500MG PACK : 1CLARITHROMYCIN TABLETS 500MG PACK : 2X7 | $9.2M | 5 | 9.3% |
| 3 | DYVENPRO DISTRIBUCION Y VENTA DEECUADOR CLARITHROMYCIN TABLETS USP 500MGCLARITHROMYCIN FOR ORAL SUSPENSION USP 2CLARITHROMYCIN FOR INFUSION BP 500 MG CL | $4.0M | 5 | 4.1% |
| 4 | HEKO PHARMACY LTDTANZANIA CLARITHROMYCIN TABLETS USP 500 MG (KLARCLARITHROMYCIN TABLETS 500 MGCLARIE OD B.N: EV12424 ,EV12524,MFG: DEC2024 EXP: NOV2028 | $3.9M | 5 | 4.0% |
| 5 | CIPLA KENYA LTD C/O IMPERIAL MANAGEKENYA ESCLAM KIT[PS:7X1X6X10100PAC=424200 NOS]PYLOKIT [52920X7X1X6'S]PYLOKIT [52653X7X1X6'S] | $3.2M | 5 | 3.3% |
| 6 | ASTRA PHARMA (T) LTDTANZANIA CLARITHROMYCIN TABLETS USP 500 MG (KLARCLARITHROMYCIN TABLETS 500 MGCLARIE OD B.N: EV12424 ,EV12524,MFG: DEC2024 EXP: NOV2028 | $3.2M | 5 | 3.3% |
| 7 | BROWN AND BURK UK LIMITEDUNITED KINGDOM CLARITHROMYCIN FILM - COATED TABLETS 250CLARIWELL (CLARITHROMYCIN 250MG/5ML POWDCLARITHROMYCIN TABLETS 500 MG 2X7'S | $2.1M | 5 | 2.2% |
| 8 | AUROLOGISTICS LLC, (AUROBINDO PHARMUNITED STATES CLARITHROMYCIN TABLETS 500 MG 60'SCLARITHROMYCIN TABLETS 500 MG 60'SNOS | $1.6M | 5 | 1.6% |
| 9 | AUROLOGISTICS LLC (AUROBINDO PHARMAUNITED STATES CLARITHROMYCIN TABLETS 500 MG 60'SCLARITHROMYCIN TABLETS 500 MG 60'SNOS | $1.6M | 5 | 1.6% |
| 10 | RISING PHARMA HOLDINGS INCUNITED STATES CLARITHROMYCIN TABLETS 500 MG 60'SCLARITHROMYCIN TABLETS 500 MG 60'SNOS | $1.3M | 5 | 1.4% |
| 11 | YUSEN LOGISTICS BENELUX BELGIUM KEETBERGLAANBELGIUM CLARITHROMYCIN BASICS TAB 500MG PACK : 1CLARITHROMYCIN TABLETS 500MG PACK : 2X7 | $1.3M | 5 | 1.3% |
| 12 | MEDLEY PHARMA LTDUNITED KINGDOM CLARITHROMYCIN FILM - COATED TABLETS 250CLARITHROMYCIN TABLETS 500 MG 2X7'SCLARITHROMYCIN 500MG TABLETS 02 X 7S B | $1.1M | 5 | 1.2% |
| 13 | ABACUS PHARMA LTDUGANDA PYLOKIT [52920X7X1X6'S]PYLOKIT [52653X7X1X6'S]PYLOKIT [50022X7X1X6'S] | $1.1M | 5 | 1.1% |
| 14 | VITAFARMA S.A.CHILE | $1.0M | 5 | 1.0% |
| 15 | MILPHARM LIMITEDUNITED KINGDOM CLARITHROMYCIN FILM - COATED TABLETS 250CLARITHROMYCIN TABLETS 500 MG 2X7'SCLARITHROMYCIN 500MG TABLETS 02 X 7S B | $997.3K | 5 | 1.0% |
Related Analysis
Market Analysis: Top Importing Countries & Importers
Comprehensive geographic market intelligence dashboard
Which companies are buying Clarithromycin — and from which countries?
Flow of Clarithromycin exports from India: each country's share and the named importers behind the numbers
Clarithromycin — Buyer Countries to Key Importers
Trade flow: top importing countries → named buyer companies
Market Analysis: Top Importing Countries & Their Importers
1United Kingdom
United Kingdom emerges as the first largest importing country, achieving a total trade value of $18.3M through 88 shipments. This represents a market share of 18.6% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: United Kingdom has a diverse importer base, with their top importers including:
• BROWN AND BURK LIMITED - $11.5M (63.0% of country's total business)
• BROWN AND BURK UK LIMITED - $2.1M (11.7% of country's total business)
• MEDLEY PHARMA LTD - $1.1M (6.2% of country's total business)
• MILPHARM LIMITED - $997.3K (5.5% of country's total business)
Key Insight: United Kingdom demonstrates strong market positioning with an average shipment value of $207.9K, indicating premium pricing strategy compared to the market average of $27.5K.
United Kingdom is a key market for Clarithromycin imports, representing 18.6% of total trade value.
2Belgium
Belgium emerges as the second largest importing country, achieving a total trade value of $11.4M through 213 shipments. This represents a market share of 11.6% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: Belgium has a diverse importer base, with their top importers including:
• YUSEN LOGISTICS BENELUX BELGIUM - $9.2M (80.8% of country's total business)
• YUSEN LOGISTICS BENELUX BELGIUM KEETBERGLAAN - $1.3M (11.5% of country's total business)
Key Insight: Belgium demonstrates strong market positioning with an average shipment value of $53.4K, indicating premium pricing strategy compared to the market average of $27.5K.
Belgium is a key market for Clarithromycin imports, representing 11.6% of total trade value.
3Tanzania
Tanzania emerges as the third largest importing country, achieving a total trade value of $8.4M through 28 shipments. This represents a market share of 8.5% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: Tanzania has a diverse importer base, with their top importers including:
• HEKO PHARMACY LTD - $3.9M (46.4% of country's total business)
• ASTRA PHARMA (T) LTD - $3.2M (38.4% of country's total business)
Key Insight: Tanzania demonstrates strong market positioning with an average shipment value of $299.6K, indicating premium pricing strategy compared to the market average of $27.5K.
Tanzania is a key market for Clarithromycin imports, representing 8.5% of total trade value.
4United States
United States emerges as the fourth largest importing country, achieving a total trade value of $8.3M through 45 shipments. This represents a market share of 8.5% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: United States has a diverse importer base, with their top importers including:
• AUROLOGISTICS LLC, (AUROBINDO PHARM - $1.6M (19.2% of country's total business)
• AUROLOGISTICS LLC (AUROBINDO PHARMA - $1.6M (18.8% of country's total business)
• RISING PHARMA HOLDINGS INC - $1.3M (16.0% of country's total business)
• RISING PHARMA HOLDINGS, INC. - $946.0K (11.3% of country's total business)
Key Insight: United States demonstrates strong market positioning with an average shipment value of $185.5K, indicating premium pricing strategy compared to the market average of $27.5K.
United States is a key market for Clarithromycin imports, representing 8.5% of total trade value.
5Kenya
Kenya emerges as the fifth largest importing country, achieving a total trade value of $5.8M through 2 shipments. This represents a market share of 5.9% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: Kenya has a diverse importer base, with their top importers including:
• CIPLA KENYA LTD C/O IMPERIAL MANAGE - $3.2M (55.9% of country's total business)
Key Insight: Kenya demonstrates strong market positioning with an average shipment value of $2.9M, indicating premium pricing strategy compared to the market average of $27.5K.
Kenya is a key market for Clarithromycin imports, representing 5.9% of total trade value.
Buyer Segment Analysis
TransData Nexus Clarithromycin buyer market intelligence
1Buyer Segment Analysis
The importation of Clarithromycin from India involves various buyer segments, each with distinct purchasing behaviors and order patterns:
1. Distributors: Entities like BROWN AND BURK LIMITED (United Kingdom) and YUSEN LOGISTICS BENELUX BELGIUM (Belgium) function as intermediaries, procuring large quantities of Clarithromycin to supply to pharmacies, hospitals, and other healthcare providers. Their bulk purchasing leverages economies of scale, and they often engage in long-term contracts to ensure consistent supply chains.
2. Hospital Groups: Organizations such as HEKO PHARMACY LTD (Tanzania) and CIPLA KENYA LTD C/O IMPERIAL MANAGE (Kenya) represent hospital networks that import Clarithromycin directly for inpatient and outpatient treatments. Their procurement is typically based on patient demand forecasts, with orders placed periodically to maintain adequate stock levels for continuous patient care.
3. Government Procurement Agencies: While not explicitly listed among the top buyers, government bodies often engage in large-scale procurement through tenders to supply public healthcare facilities. These agencies prioritize cost-effectiveness and compliance with national healthcare standards, often resulting in substantial, periodic orders aligned with budget cycles and public health initiatives.
4. Re-exporters: Companies like AUROLOGISTICS LLC (United States), associated with AUROBINDO PHARMA, may import Clarithromycin for re-export purposes. They capitalize on India's manufacturing capabilities to distribute the antibiotic to other markets, adhering to international quality standards and regulatory requirements.
5. Contract Manufacturers: Entities such as RISING PHARMA HOLDINGS INC (United States) may engage in contract manufacturing arrangements, importing Clarithromycin as an active pharmaceutical ingredient (API) for formulation into finished dosage forms. Their procurement is driven by production schedules and market demand forecasts, ensuring timely availability of the antibiotic for distribution.
Each segment's procurement strategy is influenced by factors such as regulatory compliance, market demand, and supply chain logistics, contributing to the overall dynamics of Clarithromycin imports from India.
Country-Specific Import Regulations
TransData Nexus Clarithromycin buyer market intelligence
1Country-Specific Import Regulations
The importation of Clarithromycin into the top five importing countries involves adherence to specific regulatory frameworks:
1. United Kingdom:
2. Belgium:
3. Tanzania:
4. United States:
5. Kenya:
Importers must navigate these regulatory landscapes to ensure compliance and facilitate the timely availability of Clarithromycin in these markets.
Demand Drivers & Market Opportunity
TransData Nexus Clarithromycin buyer market intelligence
1Demand Drivers & Market Opportunity
The demand for Clarithromycin across importing countries is driven by several key factors:
1. Disease Prevalence: Clarithromycin is widely used to treat respiratory tract infections, Helicobacter pylori infections, and certain skin infections. High prevalence rates of these conditions in various regions contribute to sustained demand.
2. Government Healthcare Programs: Many countries have implemented healthcare initiatives aimed at improving access to essential medicines. For instance, the inclusion of Clarithromycin in national treatment guidelines and reimbursement schemes enhances its accessibility and affordability.
3. Universal Health Coverage Expansion: Efforts to achieve universal health coverage (UHC) have led to increased procurement of essential medicines like Clarithromycin. Countries expanding their UHC programs prioritize the availability of cost-effective antibiotics to meet the healthcare needs of their populations.
4. WHO Essential Medicines List Procurement: Clarithromycin's inclusion in the World Health Organization's Essential Medicines List underscores its importance in treating common infections. This designation encourages countries to procure and stock the antibiotic to meet public health demands.
5. Tender-Based Purchasing: Many governments and large healthcare organizations utilize tendering processes to procure medicines. This approach ensures competitive pricing and consistent supply, influencing the volume and frequency of Clarithromycin imports.
With 811 buyers across 144 countries, the global market for Clarithromycin presents significant opportunities. Manufacturers and exporters can leverage these demand drivers by aligning their production and distribution strategies with the specific needs and regulatory environments of target markets.
Common Questions — Clarithromycin Buyers & Importers
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
QWho is the largest clarithromycin buyer importing from India?
Based on import volume and value, BROWN AND BURK LIMITED (UNITED KINGDOM) leads with $11.5M in imports and a 11.7% market share — the highest of any single clarithromycin importer. YUSEN LOGISTICS BENELUX BELGIUM (BELGIUM) and DYVENPRO DISTRIBUCION Y VENTA DE (ECUADOR) are the next largest buyers.
QHow many companies buy clarithromycin from India?
There are 811 active clarithromycin buyers importing from India, with a combined market of $98.4M across 3,576 shipments to 144 countries. The top 5 buyers hold 32.4% of total import value, while the remaining 806 buyers handle the other 67.6%.
QWhich countries import the most clarithromycin from India?
The top importing countries for clarithromycin from India are United Kingdom (18.6%), Belgium (11.6%), Tanzania (8.5%), United States (8.5%), Kenya (5.9%). These markets represent the largest demand centres for Indian pharmaceutical exports of clarithromycin, with buyers ranging from government procurement agencies to private pharmaceutical distributors.
QWhat is the average import order value for clarithromycin from India?
The average import transaction value for clarithromycin from India is $27.5K, with an average unit price of $64.25 per unit. Order sizes vary significantly based on buyer type — government tenders tend to be larger while private distributors place more frequent smaller orders.
Buyer Segment Analysis
TransData Nexus Clarithromycin buyer market intelligence
1Buyer Segment Analysis
The importation of Clarithromycin from India involves various buyer segments, each with distinct purchasing behaviors and order patterns:
1. Distributors: Entities like BROWN AND BURK LIMITED (United Kingdom) and YUSEN LOGISTICS BENELUX BELGIUM (Belgium) function as intermediaries, procuring large quantities of Clarithromycin to supply to pharmacies, hospitals, and other healthcare providers. Their bulk purchasing leverages economies of scale, and they often engage in long-term contracts to ensure consistent supply chains.
2. Hospital Groups: Organizations such as HEKO PHARMACY LTD (Tanzania) and CIPLA KENYA LTD C/O IMPERIAL MANAGE (Kenya) represent hospital networks that import Clarithromycin directly for inpatient and outpatient treatments. Their procurement is typically based on patient demand forecasts, with orders placed periodically to maintain adequate stock levels for continuous patient care.
3. Government Procurement Agencies: While not explicitly listed among the top buyers, government bodies often engage in large-scale procurement through tenders to supply public healthcare facilities. These agencies prioritize cost-effectiveness and compliance with national healthcare standards, often resulting in substantial, periodic orders aligned with budget cycles and public health initiatives.
4. Re-exporters: Companies like AUROLOGISTICS LLC (United States), associated with AUROBINDO PHARMA, may import Clarithromycin for re-export purposes. They capitalize on India's manufacturing capabilities to distribute the antibiotic to other markets, adhering to international quality standards and regulatory requirements.
5. Contract Manufacturers: Entities such as RISING PHARMA HOLDINGS INC (United States) may engage in contract manufacturing arrangements, importing Clarithromycin as an active pharmaceutical ingredient (API) for formulation into finished dosage forms. Their procurement is driven by production schedules and market demand forecasts, ensuring timely availability of the antibiotic for distribution.
Each segment's procurement strategy is influenced by factors such as regulatory compliance, market demand, and supply chain logistics, contributing to the overall dynamics of Clarithromycin imports from India.
Country-Specific Import Regulations
TransData Nexus Clarithromycin buyer market intelligence
1Country-Specific Import Regulations
The importation of Clarithromycin into the top five importing countries involves adherence to specific regulatory frameworks:
1. United Kingdom:
2. Belgium:
3. Tanzania:
4. United States:
5. Kenya:
Importers must navigate these regulatory landscapes to ensure compliance and facilitate the timely availability of Clarithromycin in these markets.
Demand Drivers & Market Opportunity
TransData Nexus Clarithromycin buyer market intelligence
1Demand Drivers & Market Opportunity
The demand for Clarithromycin across importing countries is driven by several key factors:
1. Disease Prevalence: Clarithromycin is widely used to treat respiratory tract infections, Helicobacter pylori infections, and certain skin infections. High prevalence rates of these conditions in various regions contribute to sustained demand.
2. Government Healthcare Programs: Many countries have implemented healthcare initiatives aimed at improving access to essential medicines. For instance, the inclusion of Clarithromycin in national treatment guidelines and reimbursement schemes enhances its accessibility and affordability.
3. Universal Health Coverage Expansion: Efforts to achieve universal health coverage (UHC) have led to increased procurement of essential medicines like Clarithromycin. Countries expanding their UHC programs prioritize the availability of cost-effective antibiotics to meet the healthcare needs of their populations.
4. WHO Essential Medicines List Procurement: Clarithromycin's inclusion in the World Health Organization's Essential Medicines List underscores its importance in treating common infections. This designation encourages countries to procure and stock the antibiotic to meet public health demands.
5. Tender-Based Purchasing: Many governments and large healthcare organizations utilize tendering processes to procure medicines. This approach ensures competitive pricing and consistent supply, influencing the volume and frequency of Clarithromycin imports.
With 811 buyers across 144 countries, the global market for Clarithromycin presents significant opportunities. Manufacturers and exporters can leverage these demand drivers by aligning their production and distribution strategies with the specific needs and regulatory environments of target markets.
Official References & Regulatory Resources
- European Medicines Agency
- WHO Essential Medicines
- Invest India — Pharma Sector
- India Trade Statistics (DGFT)
Verify import regulations and drug registration requirements with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Buyer Identification: 811 global importers of Clarithromycin identified from consignee fields in DGFT shipping bill records.
- 2.Import Value Analysis: Total import value aggregated from 3,576 individual shipping bill records. Values are FOB in USD.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation.
- 4.Geographic Distribution: Buyer imports distributed across 144 destination countries with market share per buyer calculated from capped values.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
3,576 Verified Shipments
811 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists